You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for NDC 69367-0296


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69367-0296

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
SOLIFENACIN SUCCINATE 10MG TAB AvKare, LLC 69367-0296-09 90 33.21 0.36900 2023-06-15 - 2028-06-14 FSS
SOLIFENACIN SUCCINATE 10MG TAB AvKare, LLC 69367-0296-30 30 11.17 0.37233 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Drug NDC: 69367-0296

Introduction to NDC and Drug Pricing

The National Drug Code (NDC) is a unique identifier assigned to each drug product by the FDA, helping in the tracking and management of pharmaceuticals. The NDC 69367-0296 is associated with a specific drug product, and understanding its market dynamics is crucial for pharmaceutical companies, healthcare providers, and patients.

Understanding the NDC Directory

The FDA's National Drug Code Directory is a comprehensive resource that includes information on all listed drugs in the U.S., including their NDC numbers, strengths, and other relevant details. This directory is updated daily and includes data on finished, unfinished, and compounded drug products[4].

Market Trends in Pharmaceutical Pricing

Pharmaceutical pricing is influenced by several factors, including regulatory changes, market demand, and the introduction of new drugs.

Drug Price Inflation

Recent projections indicate that drug price inflation is expected to grow, driven significantly by specialty pharmaceuticals. Vizient, Inc. projects a 3.8% increase in drug prices, the highest since July 2019, with specialty pharmacy products being a major contributor[2].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which treat complex or chronic conditions such as cancer, infectious diseases, and autoimmune disorders, are a significant factor in the rising costs. These drugs make up the majority of the top 15 medications in terms of spend among pharmacy program participants. With 42 novel specialty drugs approved in 2023 and more expected in 2024, the price increase for these medications is projected to be around 4.18%[2].

Global Pricing Comparisons

The U.S. pharmaceutical market stands out for its high drug prices compared to other regions. According to an ASPE issue brief, by 2022, prices in the U.S. were 5.5 times those in the OECD (excluding the U.S.) and 7.7 times prices in the rest of the world. This disparity is partly due to the higher average price per unit and a drug mix that skews towards more expensive compounds[3].

Specific Drug Analysis: NDC 69367-0296

To analyze the market and price projections for the drug with NDC 69367-0296, we need to identify the specific drug product associated with this code.

Drug Identification

While the specific details of the drug associated with NDC 69367-0296 are not provided in the sources, we can infer some general trends based on the broader pharmaceutical market.

Pricing Trends

Given the general trend of increasing prices in the pharmaceutical market, especially for specialty drugs, it is likely that the price of the drug associated with NDC 69367-0296 will also see an increase. Here are some key points to consider:

  • Specialty vs. Non-Specialty Drugs: If the drug is a specialty pharmaceutical, it is more likely to experience a higher price increase compared to non-specialty drugs.
  • Market Competition: The presence of biosimilars or generic alternatives can influence pricing. However, for many specialty drugs, biosimilars are still gaining market share and may not immediately impact prices significantly[2].
  • Regulatory Environment: Changes in FDA regulations or healthcare policies can affect drug pricing. For instance, the FDA's efforts to improve transparency and competition in the drug market could influence prices.

Price Projections

General Projections

Based on the overall trend, here are some general price projection considerations:

  • Annual Increase: A 3.8% to 4.18% annual increase in price is plausible, aligning with the projected increases for specialty pharmaceuticals[2].
  • Market Dynamics: The actual price increase could be higher or lower depending on the specific market dynamics, competition, and regulatory changes.

Example Pricing Scenario

For illustrative purposes, if the current price of the drug associated with NDC 69367-0296 is $100 per unit, a 4% annual increase would result in a price of $104 per unit in the next year.

Key Factors Influencing Pricing

Drug Utilization and Demand

The increasing utilization of certain drug categories, such as weight loss drugs and gene therapies, can drive up prices due to higher demand[2].

Supply Chain and Manufacturing Costs

Changes in supply chain costs, manufacturing complexities, and raw material prices can also impact the final price of the drug.

Regulatory and Policy Changes

Policy changes, such as those affecting drug pricing transparency or the approval process, can influence the market and pricing strategies.

Conclusion

The market analysis and price projections for the drug associated with NDC 69367-0296 are influenced by broader trends in the pharmaceutical industry. With the expected increase in drug prices driven by specialty pharmaceuticals and other market factors, it is crucial for stakeholders to monitor these trends closely.

Key Takeaways

  • Drug Price Inflation: Expected to grow at 3.8% driven by specialty pharmaceuticals.
  • Specialty Drugs: Higher price increases projected for specialty drugs.
  • Global Pricing Disparities: U.S. drug prices are significantly higher than in other regions.
  • Regulatory Impact: Changes in FDA regulations and healthcare policies can affect drug pricing.
  • Market Dynamics: Actual price increases can vary based on competition, demand, and supply chain factors.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique identifier assigned to each drug product by the FDA, used for tracking and managing pharmaceuticals.

Q: Why are drug prices in the U.S. higher than in other countries? A: Drug prices in the U.S. are higher due to a combination of factors including higher average prices per unit and a drug mix that skews towards more expensive compounds.

Q: How do specialty pharmaceuticals impact drug pricing? A: Specialty pharmaceuticals, which treat complex conditions, are a significant factor in rising drug costs and are projected to see higher price increases.

Q: What role do biosimilars play in drug pricing? A: Biosimilars can reduce prices by increasing competition, but their impact is gradual, and they are expected to gain more market share over time.

Q: How do regulatory changes affect drug pricing? A: Regulatory changes can influence transparency, competition, and the approval process, all of which can impact drug pricing strategies.

Sources

  1. YouTube - NDC Directory (March 2015)
  2. Vizient Inc. - Pharmacy Market Outlook (January 2024)
  3. ASPE Issue Brief - International Market Size and Prices (December 2024)
  4. FDA - National Drug Code Directory (November 2024)
  5. Missouri Department of Social Services - Specialty MAC Name of Drug (January 2023)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.